[go: up one dir, main page]

HK1077003B - 含有拉莫三嗪的缓释配方 - Google Patents

含有拉莫三嗪的缓释配方 Download PDF

Info

Publication number
HK1077003B
HK1077003B HK05108373.5A HK05108373A HK1077003B HK 1077003 B HK1077003 B HK 1077003B HK 05108373 A HK05108373 A HK 05108373A HK 1077003 B HK1077003 B HK 1077003B
Authority
HK
Hong Kong
Prior art keywords
lamotrigine
release
pharmaceutically acceptable
weight
sustained release
Prior art date
Application number
HK05108373.5A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1077003A1 (zh
Inventor
Ian Richard Buxton
Robin Currie
Myrna A. Dela-Cruz
Gary Wayne Goodson
Wlodzimierz Karolak
Mehran Maleki
Vijay Mohan Iyer
Gopal Muppirala
Alan Frank Parr
Jagdev Singh Sidhu
Robert Allen Stagner
Akunuri Venkata Vijay-Kumar
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0217493A external-priority patent/GB0217493D0/en
Priority claimed from GB0217492A external-priority patent/GB0217492D0/en
Priority claimed from GB0313801A external-priority patent/GB0313801D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Priority claimed from PCT/EP2003/008368 external-priority patent/WO2004012741A1/en
Publication of HK1077003A1 publication Critical patent/HK1077003A1/zh
Publication of HK1077003B publication Critical patent/HK1077003B/zh

Links

HK05108373.5A 2002-07-29 2003-07-28 含有拉莫三嗪的缓释配方 HK1077003B (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0217492.8 2002-07-29
GB0217493A GB0217493D0 (en) 2002-07-29 2002-07-29 Novel methods of treatment
GB0217492A GB0217492D0 (en) 2002-07-29 2002-07-29 Novel method of treatment
GB0217493.6 2002-07-29
GB0313801.3 2003-06-13
GB0313801A GB0313801D0 (en) 2003-06-13 2003-06-13 Novel methods of treatment
PCT/EP2003/008368 WO2004012741A1 (en) 2002-07-29 2003-07-28 Sustained release formulations comprising lamotrigine

Publications (2)

Publication Number Publication Date
HK1077003A1 HK1077003A1 (zh) 2006-02-03
HK1077003B true HK1077003B (zh) 2009-09-04

Family

ID=

Similar Documents

Publication Publication Date Title
EP1524981B1 (en) Sustained release formulations comprising lamotrigine
US8637512B2 (en) Formulations and method of treatment
AU2003260336B2 (en) Sustained release formulations comprising lamotrigine
KR101489401B1 (ko) 약 염기성 약물과 유기산을 포함하는 약물 전달 시스템
EP1576986A2 (en) Sustained-release tramadol formulations with 24-hour clinical efficacy
US20080292695A1 (en) Carvedilol forms, compositions, and methods of preparation thereof
KR20090057410A (ko) 약 염기성 약물의 고용체를 포함하는 약물 전달 시스템
US20220105055A1 (en) Abuse-deterrent dosage forms containing esketamine
US20090028935A1 (en) Carvedilol forms, compositions, and methods of preparation thereof
MXPA05004338A (es) Composiciones de liberacion sostenida que contienen alfuzosin.
EP2010158B1 (en) Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
WO2009027786A2 (en) Matrix dosage forms of varenicline
CN101229169B (zh) 含拉莫三嗪的缓释制剂
US20090130206A1 (en) Controlled Release Compositions of an Antidepressant Agent
HK1077003B (zh) 含有拉莫三嗪的缓释配方
AU2007202294A1 (en) Sustained release formulations comprising lamotrigine
AU2013202441B2 (en) Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
EP4433034A1 (en) Controlled release formulations of flavoxate and process for preparation thereof